Management of primary malignant epithelial parotid tumors

Surgical Oncology

Volumn 13, Issue 1, 2004, Pages 7-16

  Harish, K ^a,b  

^a M S RAMAIAH MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

Diagnosis; Histopathology; Neck dissection; Parotid cancer; Staging

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; NAVELBINE; PACLITAXEL;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; EPITHELIUM TUMOR; FACIAL NERVE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MULTIMODALITY CANCER THERAPY; NECK METASTASIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND TUMOR; PAROTIDECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TISSUE SECTION; TREATMENT PLANNING;

EID: 2342543251     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2003.10.002     Document Type: Article

References (81)

1. Luna MA. Pathology of tumors of the salivary glands. In: Thawley SE, Panje WR, Batsakis JG, Lindberg RD, editors. Comprehensive management of head and neck tumors, 2nd ed. London: WB Saunders Company; 1999. p. 1106-46.
2. Sobin LH, Wittekind CH, editors. UICC TNM classification of malignant tumors, 5th ed. New York: Wiley-Liss; 1997.
3. Som P.M., Biller H.F. High-grade malignancies of the parotid gland. identification with MR imaging Radiology. 173(3):1989;823-826
4. Som P.M., Shugar J.M., Sacher M., Stollman A.L., Biller H.F. Benign and malignant parotid pleomorphic adenomas. CT and MR studies Journal of Computer Assisted Tomography. 12(1):1988;65-69
5. Trappe M., Marsot-Dupuch K., Le Roux C. Study of the salivary glands in 1990. Annals of Radiology. 34(1-2):1991;98-109
6. Freling N.J.M., Molenaar W.M., Vermey A., et al. Malignant parotid tumors. clinical use of MR imaging and histologic correlation Radiology. 185(3):1992;691-696
7. Tsushima Y., Matsumuto M., Endo K., Aihara T., Nakajima T. Characteristic bright signal of parotid pleomorphic adenomas on T2 weighted MR images with pathological correlation. Clinical Radiology. 49(7):1994;485-489
8. O'Brien C.R., Malka V.B., Mijailovic M. Evaluation of 242 consecutive parotidectomies performed for benign and malignant disease. Australian and New Zealand Journal of Surgery. 63(11):1993;870-877
9. Miller F.R., Wanamaker J.R., Lavertu P., Wood B.G. Magnetic resonance imaging and the management of parapharyngeal space tumors. Head and Neck. 18(1):1996;67-77
10. Parker G.D., Harnsberger H.R. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics. 11(3):1991;383-399
11. McGhee R.B., Chakeres D.W., Schmalkbrock P., Brogan M.A., Negulesco J.A. The extracranial facial nerve. high-resolution three-dimensional Fourier transform MR imaging AJNR American Journal of Neuroradiology. 14(2):1993;465-472
12. Hofffman H, Funk G, Endres D. Evaluation and surgical treatement of tumors of the salivary glands. In: Thawley SE, Panje WR, Batsakis JG, Lindberg RD, editors. Comprehensive management of head and neck tumors, 2nd ed. London: WB Saunders Company; 1999. p. 1147-81.
13. Krause C.J. The management of parotid neoplasms. Head and Neck Surgery. 3(4):1981;340-343
14. Stafford N.D., Wilde A. Parotid cancer. Surgical Oncology. 6(4):1997;209-213
15. Hee C.G., Perry C.F. Fine-needle aspiration cytology of parotid tumours. is it useful? Australian and New Zealand Journal of Surgery. 71(6):2001;345-348
16. Zurrida S., Alasio L., Tradati N., Bartoli O., Chiesa F., Pilotti S. Fine needle aspiration of parotid masses. Cancer. 72(8):1993;2306-2311
17. Heller K.S., Attie J.N., Dubner S. Accuracy of frozen section in the evaluation of salivary tumors. American Journal of Surgery. 166(4):1993;424-427
18. Orell SR, Sterrett GF, Walters MNI, Whitaker D, editors. Manual and atlas of fine needle aspiration cytology. New York, NY, Orlando, FL: Churchill Livingstone, Harcourt Brace; 1999. p. 41-3.
19. Boccato P., Altavilla G., Blandamura S. Fine needle aspiration biopsy of salivary gland lesions. A reappraisal of pitfalls and problems. Acta Cytologica. 42(4):1998;888-898
20. Stewart C.J., MacKenzie K., McGarry G.W., Mowat A. Fine-needle aspiration cytology of salivary gland. a review of 341 cases Diagnostic Cytopathology. 22(3):2000;139-146
21. Miller R.H., Calcaterra T.C., Paglia D.E. Accuracy of frozen section diagnosis of parotid lesions. Annals of Otology Rhinology and Laryngology. 88:1979;573-576
22. Carvalho M.B., Soares J.M., Rapoport A., et al. Perioperative frozen section examination in parotid gland tumors. Sao Paulo Medical Journal. 117(6):1999;233-237
23. Rigual N.R., Milley P., Lore J.M., Kaufman S. Accuracy of frozen-section diagnosis in salivary gland neoplasms. Head and Neck Surgery. 8(6):1986;442-446
24. Tew S., Poole A.G., Philips J. Fine-needle aspiration biopsy of parotid lesions. comparison with frozen section Australian and New Zealand Journal of Surgery. 67(7):1997;438-441
25. Megerian C.A., Maniglia A.J. Parotidectomy. a 10-year experience with fine needle aspiration and frozen section biopsy correlation Ear, Nose and Throat Journal. 73(6):1994;377-380
26. Batsakis J.G., Chinn E., Regezi J.A., Repola D.A. The pathology of head and neck tumors II. salivary glands Head and Neck Surgery. 1(2):1978;167-180
27. Laudadio P., Caliceti U., Cerasoli P.T., Rinaldi Ceroni A. Mucoepidermoid tumor of the parotid gland. a very difficult prognostic evaluation Clinical Otolaryngology. 12(3):1987;177-182
28. O'Brien C.J., Soong S.J., Herrera G.A., Urist M.M., Maddox W.A. Malignant salivary tumors. analysis of prognostic factors and survival Head and Neck Surgery. 9(2):1986;82-92
29. Beahrs O.H., Chong G.C. Management of facial nerve in parotid gland surgery. American Journal of Surgery. 124(4):1972;473-476
30. Skolnik E.M., Friedman M., Becker S., Sisson G.A., Keyes G.A. Tumors of the major salivary glands. Laryngoscope. 87(6):1977;843-861
31. Matsuba H.M., Thawley S.E., Devineni V.R., Levine L.A., Smith P.G. High grade malignancies of parotid gland. effective use of planned surgery and irradiation Laryngoscope. 95:1985;1059-1063
32. Frankenthaler R.A., Luna M.A., Lee S.S., et al. Prognostic variables in parotid gland cancer. Archives of Otolaryngology-Head and Neck Surgery. 117(11):1991;1251-1256
33. Armstrong J.G., Harrison L.B., Thaler H.T., et al. The indication of elective treatment of the neck in cancer of the major salivary glands. Cancer. 69(3):1992;615-619
34. Kelley D.J., Spiro R.H. Management of the neck in parotid carcinoma. American Journal of Surgery. 172(6):1996;695-697
35. Shah J. Management of regional metastasis in salivary and thyroid cancer. Larson D., Ballantyne A., Guillamondegui O. Cancer of the neck: evaluation and treatment. 1986;253-258 Macmillan, New York
36. Korkmaz H., Yoo G.H., Du W. Predictors of nodal metastasis in salivary gland cancer. Journal of Surgical Oncology. 80(4):2002;186-189
37. Byers R.M. The use of post operative radiation. Its goals and 1978 attainments. Larygoscope. 89(4):1979;567-572
38. Fu K., Leibel S., Levine M., Friedlander L.M., Boles R., Phillips T.L. Carcinoma of the major salivary glands. Analysis of treatment results and sites and causes of failures. Cancer. 40(6):1977;2882-2890
39. King J., Fletcher G. Malignant tumors of the major salivary glands. Radiology. 100(2):1971;381-384
40. Jackson G., Luna M., Byers R. Results of surgery alone and surgery combined with post operative radiotherapy in the treatment of cancer of the parotid gland. American Journal of Surgery. 146(4):1983;497-500
41. Frankenthaler R.A., Byers R.M., Luna M.A., Callender D.L., Wolf P., Goepfert H. Predicting occult lymph nodal metastasis in parotid cancer. Archives of Otolaryngology-Head and Neck Surgery. 119(5):1993;517-520
42. Conley J., Hamaker R.C. Prognosis of malignant tumors of the parotid gland with facial paralysis. Archives of Otolaryngology. 101(1):1975;34-44
43. Bhattacharyya N., Fried M.P. Nodal metastasis in major salivary gland cancer. predictive factors and effects on survival Archives of Otolaryngology-Head and Neck Surgery. 128(8):2002;904-908
44. Bardwill J.M. Tumors of the parotid gland. American Journal of Surgery. 114(4):1967;498-502
45. Johns M.E. Parotid cancer. a rational basis for treatment Head and Neck Surgery. 3(2):1980;132-144
46. Spiro R.H., Armstrong J.G., Harrison L.B., Geller N.L., Lin S.Y., Strong E.W. Carcinoma of major salivary glands. Recent trends. Archives of Otolarygology-Head and Neck Surgery. 115(3):1989;316-321
47. Califano L., Zupi A., Massari S., Giardino C. Indication for neck dissection in carcinoma of the parotid gland. Our experience in 39 cases. International Surgery. 78(4):1993;347-349
48. Ball A.B., Fish S., Thomas J.M. Malignant epithelial parotid tumors. a rational treatment policy British Journal of Surgery. 82(5):1995;621-623
49. McGuirt W.F. Management of occult metastatic disease from salivary gland neoplasms. Archives of Otolaryngology-Head and Neck Surgery. 115(3):1989;322-325
50. Medina J.E. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngologic Clinics of North America. 31(5):1998;815-822
51. Shidnia H, Hornback NB. Radiation therapy of tumors of the salivary glands. In: Thawley SE, Panje WR, Batsakis JG, Lindberg RD, editors. Comprehensive management of head and neck tumors, 2nd ed. London: WB Saunders Company; 1999. p. 1182-96.
52. Armstrong J.G., Harrison L.B., Spiro R.H., Fass D.E., Strong E.W., Fuks Z.Y. Malignant tumors of the major salivary gland origin. a matched pair analysis of the role of combined surgery and post operative radiotherapy Archives of Otolaryngology-Head and Neck Surgery. 116(3):1990;290-293
53. Johns M.E., Goldsmith M.M. Current management of salivary gland tumors (part 2). Oncology. 3(3):1989;85-91. (discussion 94, 99)
54. Shidnia H., Hornback N.B., Hamaker R., Lingeman R. Carcinoma of major salivary glands. Cancer. 45(4):1980;693-697
55. Laramore G.E., Krall J.M., Griffin T.W., et al. Neutron versus photon irradiation for unresectable salivary gland tumors. final report of an RTOG-MRC randomized clinical trial. Radiation therapy oncology group Medical Research Council International Journal of Radiation Oncology Biology Physics. 27(2):1993;235-240
56. Schmitt G., Wambersie A. Review of the clinical results of fast neutron therapy. Radiotherapy and Oncology. 17(1):1990;47-56
57. Guillamondegui O.M., Byers R.M., Luna M.A., Chiminazzo H., Jesse R.H., Fletcher G.H. Aggressive surgery in treatment for parotid cancer. the role of adjunctive postoperative radiotherapy American Journal of Roentgenology Radium Therapy and Nuclear Medicine. 123(1):1975;49-54
58. Wahlberg P., Anderson H., Biorklund A., Moller T., Perfekt R. Carcinoma of the parotid and submandibular glands - a study of survival in 2465 patients. Oral Oncology. 38(7):2002;706-713
59. Batsakis J.G. Pathology consultation. Metastatic patterns of salivary gland neoplasms. Annals of Otology Rhinology and Laryngology. 91:1982;465-466
60. Twardzik F.G., Sklaroff D.M. Growth analysis of pulmonary metastases from salivary gland tumors. American Journal of Roentgenology. 126(3):1976;493-499
61. Umeda M., Nishimatsu N., Masago H., et al. Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics. 88(4):1999;473-478
62. Airoldi M., Fornari G., Pedani F., et al. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Research. 20(5C):2000;3781- 3783
63. Vermorken J.B., Verweij J., de Mulder P.H., et al. Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck. a phase II study of the EORTC Head and Neck Cancer Cooperative Group Annals of Oncology. 4(9):1993;785-788
64. de Haan L., De Mulder P., Vermorken J., Schornagel J.H., Vermey A., Verweij J. Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck. Head and Neck. 14(4):1992;273-277
65. Hill M., Constenla D., A'Hern R., et al. Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncology. 33(4):1997;275-278
66. Belani C.P., Eisenberger M.A., Gray W.C. Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Medical and Pediatric Oncology. 16(3):1988;197-202
67. Airoldi M., Brando V., Giordano C., et al. Chemotherapy for recurrent salivary gland malignancies. experience of the ENT department of Turin University ORL Journal of Otorhinolaryngology and Related Specialities. 56(2):1994;105-111
68. Posner M.R., Ervin T.J., Weichselbaum R.R., Fabian R.L., Miller D. Chemotherapy of advanced salivary gland neoplasms. Cancer. 50(11):1982;2261-2264
69. Harbo G., Bundgaard T., Pedersen D., Sogaard H., Overgaard J. Prognostic indicators for malignant tumours of the parotid gland. Clinical Otolaryngology. 27(6):2002;512-516
70. Spiro R.H., Huvos A.G., Strong E.W. Acinic cell carcinoma of salivary origin. a clinicopathologic study of 67 cases Cancer. 41(3):1978;924-935
71. Spiro R.H., Huvos A.G., Strong E.W. Adenocarcinoma of salivary origin. clinicopathologic study of 204 cases American Journal of Surgery. 144(4):1982;423-431
72. Johns ME, Nachlas NE. Salivary gland tumors. In: Paparella MM, Schumrick DA, Gluckman JL, Meyerhoff WL, editors. Otolaryngology, 3rd ed. London: WB Saunders Company; 1991. p. 2099-127.
73. Rossman K.J. The role of radiation therapy in the treatment of parotid carcinomas. American Journal of Roentgenology Radium Therapy and Nuclear Medicine. 123(3):1975;492-499
74. Eneroth C.M. Facial nerve paralysis. a criterion of malignancy in parotid tumors Archives of Otolaryngology. 95(4):1972;300-304
75. Eneroth C.M., Andreasson L., Beran M., et al. Preoperative facial paralysis in malignant parotid tumours. ORL Journal of Otorhinolaryngology and Related Specialities. 39(5):1977;272-277
76. Spiro J.D., Spiro R.H. Cancer of the parotid gland. role of 7th nerve preservation World Journal of Surgery. 27(7):2003;863-867
77. Hodgkinson D.J., Woods J.E. The influence of facial-nerve sacrifice in surgery of malignant parotid tumors. Journal of Surgical Oncology. 8(5):1976;425-432
78. Work W.P. Therapy of salivary gland tumors. Archives of Otolaryngology. 83(2):1966;89-91
79. Woods J.E., Chong G.C., Beahrs O.H. Experience with 1360 primary parotid tumors. American Journal of Surgery. 130(4):1975;460-462
80. Hanna D.C., Dickason W.L., Richardson G.S., Gaisford J.C. Management of recurrent salivary gland tumors. American Journal of Surgery. 132(4):1976;453-458
81. Hollander L., Cunningham M.P. Management of cancer of the parotid gland. Surgical Clinics of North America. 53(1):1973;113-119